Zafgen | Evaluate

Soleno slims down

The group’s diazoxide choline becomes the latest biotech project to fail in Prader-Willi syndrome.

Semaglutide repeats the obesity trick

March 12, 2019

Zafgen swings and misses a third time

November 27, 2018

Zafgen shares tumble as FDA slaps it with another clinical hold

August 28, 2018

Data point - How slimming down is growing up

June 25, 2018

ADA – Diabetes results resuscitate Zafgen, for now

March 09, 2018

Snippet roundup: A fillip for Pfizer but Merck KGaA comes under pressure

May 05, 2017

Zafgen gets one last fat chance

July 20, 2016

The end of another chapter in obesity drug development

January 20, 2016

Zafgen surprises again, but bigger questions remain

January 07, 2016

Wobbles aside, small pharma shares broadly on the up in 2015

Load More